DWIBS (Diffusion-weighted Whole body Imaging with background suppression) is a whole body diffusion-weighted magnetic resonance imaging technique with background suppression. The purpose of this technique is to evaluate lesions of the whole body in the early detection of cancer, lymph nodes, and to analyze and monitor malignant lesions.

Many people who have received cancer treatment are at risk of developing long-term side effects. The evaluation and treatment of these late effects is an important part of care and treatment.

Trilaciclib is a kinase inhibitor. Because of this use, Trilaciclib is used to treat some cases of cancer patients. Here is some information to help you better understand Trilaciclib.